Limitless Podcast

OpenAI just notched a real biology win: a tiny 4B-parameter model (“GPT-4B-micro”) designed Yamanaka-factor protein variants that jumped lab hit rates from ~0.1% to 30–50% in tests with Retro Biosciences. We unpack how a small, domain-tuned GPT can actually reprogram cells, what partial vs full age reversal could mean, and why this points to personalized longevity. We contrast OpenAI’s approach with Google’s AlphaFold push and outline the road from early results to therapies (think years of trials, roughly 7–12). If you want the fountain-of-youth story grounded in mechanisms, math, and lab-verified results, this episode is it.

------
🌌 LIMITLESS HQ: LISTEN & FOLLOW HERE ⬇️
https://limitless.bankless.com/
https://x.com/LimitlessFT
------

TIMESTAMPS

0:00 The Fountain of Youth Unveiled
1:17 Understanding Yamanaka Factors
5:16 Breakthrough with AI Protein Design
8:41 The Implications of Reversing Aging
15:12 Aging as a Disease
19:04 The Future of AI in Science
20:55 The Path to Age Reversal
21:50 Exciting Developments Ahead

------
RESOURCES

OpenAI Paper: https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences/

Josh: https://x.com/Josh_Kale

Ejaaz: https://x.com/cryptopunk7213

------
Not financial or tax advice. See our investment disclosures here:
https://www.bankless.com/disclosures⁠